Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Cancer Drugs Market Research Reports

Titlepublishedprice

Global Polymer Drug Conjugates Market Research Report 2017

By QYResearch Group
"...... , consumption, revenue (million USD), market share and growth rate of Polymer Drug Conjugates in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Southeast Asia ......"
20-Jul-2017$2900

Asia-Pacific Megestrol Market Report 2017

By QYResearch Group
"...... , revenue (Million USD), market share and growth rate of Megestrol for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan - India - Southeast Asia - Australia......"
20-Jul-2017$4000

EMEA (Europe, Middle East and Africa) Methotrexate Market Report 2017

By QYResearch Group
"...... T) , revenue (Million USD) , market share and growth rate of Methotrexate for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East: Saudi Arabia, Israel, UAE and Iran;......"
19-Jul-2017$4000

United States Paclitaxel Market Report 2017

By QYResearch Group
"...... The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate of Paclitaxel in these regions, from 2012 to 2022 (foreca......"
18-Jul-2017$3800

United States Cancer Treatment Drugs Market by Manufacturers, States, Type and Application, Forecast to 2022

By Global Info Research
"...... ncer Treatment Drugs in United States market, to split the market based on manufacturers, states, type and application.Market Segment by Manufacturers, this report coversRoche Novartis Celgene ......"
18-Jul-2017$4480

2017-2022 Cyclophosphamide Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

By QYResearch Group
"...... ications/end industries. The global Cyclophosphamide market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Asia-Pacific......"
18-Jul-2017$2960

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Mitomycin C Market 2017 Forecast to 2022

By Global Info Research
"...... (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).Scope of the Report:This report focuses on the Mitomycin C in Global market, especially in North America, Europe and Asia-Pacific, South America, Mid......"
17-Jul-2017$4880

Oncology Drugs Market Global Report 2017 Including: Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Non-Small Cell Lung Cancer , Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, Aids-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicular Cancer, Hepatocellular (Liver) Cancer, Mouth Cancer, Neuroblastoma) Covering: F. Hoffmann-La Roche Ltd, Novartis

By The Business Research Company
"...... re focusing on the R&D of new technologies such as next generation sequencing to develop MABs that are used for the development of chronic diseases such as cancer and other chronic diseases. The Oncology Drugs Market Global Report prov......"
17-Jul-2017$4000

EMEA (Europe, Middle East and Africa) Cyclophosphamide Market Report 2017

By QYResearch Group
"...... (MT), revenue (Million USD), market share and growth rate of Cyclophosphamide for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East: Saudi Arabia, Israel, UAE and Iran;......"
13-Jul-2017$4000

Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors

By GBI Research
"...... disease, the migration of the cancer cells to other parts of the body. Cancer is a genetically driven disease, with iterative mutations providing selective advantages to the cells in the context of the specific tissue site, followed by clonal expans......"
13-Jul-2017$4995

Avail upto 25% Discount on below Publisher Reports.